Inflation Reduction Act - Wednesday | Nov. 16 | 11 to noon | via Zoom

Please register here; email [email protected] or call 202-364-7602 at least one week in advance.

There are so many benefits to the Inflation Reduction Act that was passed in August. According to a statement released by The White House on August 15, the Inflation Reduction Act will lower costs for families, combat the climate crisis, reduce the deficit, and ask the largest corporations to pay their fair share. Let’s dig a little deeper to see how Medicare beneficiaries will be affected. Stephanie Kennan will discuss the recently passed legislation that redesigned Medicare Part D (the drug benefit) and permits Medicare to negotiate drug prices among other drug pricing reforms. Ms. Kennan will explain the significance of the legislation to Medicare beneficiaries as well as when the drug pricing reforms will begin. There will be plenty of time for questions and answers.

Stephanie Kennan is a senior vice president at McGuire Woods Consulting where she leads their federal health team. Her experience includes working for two members of the U.S. House of Representatives and for a U.S. Senator. She has served as director of Federal Relations for the Maryland Department of Health; as assistant director of Government Affairs for the American College of Emergency Physicians; and as a legislative representative for AARP. 

Ms. Kennan is a graduate of the University of Virginia, earned her MBA from George Washington University and an MA in creative writing from Johns Hopkins University. She is a member of the Executive Committee of the Board of Directors of the Myocarditis Foundation, a nonprofit organization that is dedicated to raising global awareness of this under diagnosed disease and advancing the scientific knowledge.

Please register here; email [email protected] or call 202-364-7602 at least one week in advance.

Wednesday | Nov. 16 | 11 to noon | via Zoom